ClinicalTrialsFinder

Initially Unresectable Clinical Trials in Shanghai

1 recruitingShanghai, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer

Gallbladder CancerInitially Unresectablethe First Line Treatment
Lu Wang, MD, PhD50 enrolled1 locationNCT05757336